...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Increased Incidence of Mixed Chimerism with the Use of Fludarabine - Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major

【24h】

Increased Incidence of Mixed Chimerism with the Use of Fludarabine - Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major

机译：重症地中海贫血接受同种异体干细胞移植的病人使用氟达拉滨-硫丹的调理混合嵌合症的发病率增加。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2015年第1期|共2页
作者
George Biju; Viswabandya Auro; Abraham Aby; Sindhuvi Eunice; Ganapule Abhijeet; Fouzia N. A.; Korula Anu; Srivastava Alok; Mathews Vikram;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Increased Incidence of Mixed Chimerism with the Use of Fludarabine - Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major [J] . George Biju, Viswabandya Auro, Abraham Aby, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：重症地中海贫血接受同种异体干细胞移植的病人使用氟达拉滨-硫丹的调理混合嵌合症的发病率增加。
2. Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation [J] . I. W. Blau, Martin Schmidt-Hieber, N. Leschinger, Annals of Hematology . 2007,第8期

机译：同种异体干细胞移植前用氟达拉滨和硫磺降低强度调节后的移植动力学和造血嵌合
3. Busulfan/Fludarabine- or Treosulfan/Fludarabine-Based Conditioning Regimen in Patients with Wiskott-Aldrich Syndrome Given Allogeneic Hematopoietic Cell Transplantation - an EBMT Inborn Errors Working Party and Scetide Retrospective Analysis [J] . Albert Michael H., Slatter Mary, Gennery Andrew, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Wiskott-Aldrich综合征患者的Busulfan / Fludarabine或葡萄牙甘露滨/氟氨酰胺的调理方案给予同种异体造血细胞移植 - EBMT天生不经说的工作缔约方和克萨雷德回顾性分析
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts [O] . Vikram Mathews, Biju George, Auro Viswabandya, -1

机译：接受基于硫丹的条件疗法和外周血干细胞移植的HLA匹配相关同种异体干细胞移植的高危β地中海贫血重症患者的改善的临床结果
7. Increased Incidence of Mixed Chimerism with the Use of Fludarabine – Treosulfan Based Conditioning in Patients Undergoing Allogeneic Stem Cell Transplantation for Thalassaemia Major [O] . George Biju, Viswabandya Auro, Abraham Aby, 2015

机译：重症地中海贫血症接受异基因干细胞移植的患者中使用氟达拉滨-基于硫丹的调理混合嵌合体的发生率增加

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号